In CESC, LUAD, HNSC and KIRC, TGM3 expression was positively correlated with these oncogenic pathways, including AKT-, ERBB2-, LTE2-, and KRAS-related pathways. Here, ERBB2 is linked to cervical squamous cell carcinoma.